| Literature DB >> 24122334 |
Vanessa Lopes-Rodrigues1, Hugo Seca, Diana Sousa, Emília Sousa, Raquel T Lima, M Helena Vasconcelos.
Abstract
Overexpression of P-glycoprotein (P-gp) contributes to the multidrug resistance (MDR) phenotype found in many cancer cells. P-gp has been identified as a promising molecular target, although attempts to find successful therapies to counteract its function as a drug efflux pump have largely failed to date. Apart from its role in drug efflux, P-gp may have other cellular functions such as being involved in apoptosis, and is found in various locations in the cell. Its expression is highly regulated, namely by microRNAs (miRNAs or miRs). In addition, P-gp may regulate the expression of miRs in the cell. Furthermore, both P-gp and miRs may be found in microvesicles or exosomes and may be transported to neighboring, drug-sensitive cells. Here, we review this current issue together with recent evidence of this network of interactions between P-gp and miRs.Entities:
Keywords: P-glycoprotein; cancer; drug resistance; exosomes; microRNAs; microvesicles
Mesh:
Substances:
Year: 2013 PMID: 24122334 DOI: 10.1002/ijc.28500
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396